
USD $736.20
Xtandi is a prescription medication that contains the active ingredient Enzalutamide. It is primarily used in the treatment of prostate cancer, particularly in patients who have previously received other therapies. Enzalutamide works by inhibiting the action of androgens, which are hormones that can promote the growth of prostate cancer cells.
Xtandi (Enzalutamide) 40mg x 112 Soft Capsules is a prescription medication used for the treatment of prostate cancer. It works by inhibiting the androgen receptor signaling pathway, which is crucial for the growth and spread of cancer cells in men with metastatic castration-resistant prostate cancer (mCRPC).
Xtandi is indicated for the treatment of:
The recommended dosage of Xtandi is 160 mg (four 40 mg soft capsules) taken orally once daily. It can be taken with or without food. It is important to swallow the capsules whole and not to chew or open them.
Common side effects of Xtandi may include:
Patients should report any severe side effects to their healthcare provider immediately.
Before starting treatment with Xtandi, patients should inform their healthcare provider of any pre-existing conditions, especially:
Xtandi may interact with other medications. Patients should provide their healthcare provider with a complete list of all medications, supplements, and herbal products they are currently taking.
Store Xtandi at room temperature, away from moisture and heat. Keep out of reach of children.
Xtandi (Enzalutamide) offers a targeted approach to managing prostate cancer, providing patients with an effective treatment option. Always consult with a healthcare professional before starting any new medication.